Medical Weight Loss for Peabody, Massachusetts Residents

Peabody, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Peabody through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Massachusetts: there is no local Peabody office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Peabody Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Peabody a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Massachusetts. That is the entire promise, and we keep it.

Peabody is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Peabody address.

Your zip code in Peabody, Massachusetts does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout downtown Peabody and the North Shore of Essex County. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Peabody you are.

Your zip code inside Massachusetts does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. Getting started in Peabody is simple: a Massachusetts licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. Across the densely populated communities of Massachusetts, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Peabody telehealth visits.

How Telehealth Works for Peabody

Here is how the whole thing works, start to finish, for anyone in Peabody.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Peabody address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Peabody

Does New Hope Weight Loss have a presence in Peabody?

Our presence in Peabody is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Peabody, Massachusetts patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Peabody patient complete care without leaving home?

Yes, staying home is the norm. Everything for Peabody patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Peabody in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Peabody patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Peabody.

What areas of Peabody do you serve?

We serve patients from across Peabody by telehealth, including downtown Peabody and the North Shore of Essex County.

Is telehealth treatment as thorough as an in-person visit for Peabody patients?

Yes. Peabody patients get the same physician review by Dr. Sharma, the same contraindication screening, the same dose titration, and the same health-advisor support as any patient. Everything except a physical exam is handled by secure video, and compounded medication ships to your door. Telehealth eligibility is confirmed during the consultation.

Peabody Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Peabody, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.